{
    "nct_id": "NCT00846703",
    "official_title": "Clinical Study of GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia in Guangdong Province",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Cytologically proven acute lymphoblastic leukemia (ALL)\n* No relapse of a previously unrecognized ALL\n* Patients must meet one of the following risk criteria:\n* Standard-risk (SR) group meeting all of the following criteria:\n* Blasts \\< 1,000/μL in peripheral blood (PB) on day 8\n* Aged 1 to \\< 6 years\n* Initial WBC \\< 20,000/μL\n* M1 (5%) or M2 (≥ 5% to \\< 25%) blasts in bone marrow on day 15;\n* M1 marrow on day 33.\n* Intermediate-risk (IR) group meeting all of the following criteria:\n\n  * Aged \\< 1 or ≥ 6 years and/or WBC ≥ 20,000/μL\n  * Blasts \\< 1,000/μL in PB on day 8\n  * M1 or M2 marrow on day 15\n  * M3 (≥ 25%) marrow on day 15 OR meets SR criteria but M3 marrow on day 15 and \\*M1 marrow on day 33.\n* High-risk (HR) group meeting ≥ 1 of the following criteria:\n\n  * Meets IR criteria and M3 marrow on day 15 (not SR and M3 on day 15)\n  * Blasts ≥ 1,000/μL in PB on day 8\n  * M2 or M3 marrow on day 33\n  * Translocation t(9;22) \\[BCR/ABL+\\] (Philadelphia chromosome-positive) or t(4;11) \\[MLL/AF4+\\].\n\nExclusion Criteria:\n\n* No Down syndrome\n* No other major disease that prohibits study treatment (e.g., severe congenital heart disease)\n* Not requiring significant therapy modification owing to study therapy associated complications\n* No complications due to other interventions\n* No one with missing data that are needed for the differential diagnosis, or for selection of the proper therapy arm\n\nsex: ALL\n\nmaximumAge: 16 Years\n\nstdAges: ['CHILD']",
        "inclusion": "* Cytologically proven acute lymphoblastic leukemia (ALL)\n* No relapse of a previously unrecognized ALL\n* Patients must meet one of the following risk criteria:\n* Standard-risk (SR) group meeting all of the following criteria:\n* Blasts < 1,000/μL in peripheral blood (PB) on day 8\n* Aged 1 to < 6 years\n* Initial WBC < 20,000/μL\n* M1 (5%) or M2 (≥ 5% to < 25%) blasts in bone marrow on day 15;\n* M1 marrow on day 33.\n* Intermediate-risk (IR) group meeting all of the following criteria:\n\n  * Aged < 1 or ≥ 6 years and/or WBC ≥ 20,000/μL\n  * Blasts < 1,000/μL in PB on day 8\n  * M1 or M2 marrow on day 15\n  * M3 (≥ 25%) marrow on day 15 OR meets SR criteria but M3 marrow on day 15 and *M1 marrow on day 33.\n* High-risk (HR) group meeting ≥ 1 of the following criteria:\n\n  * Meets IR criteria and M3 marrow on day 15 (not SR and M3 on day 15)\n  * Blasts ≥ 1,000/μL in PB on day 8\n  * M2 or M3 marrow on day 33\n  * Translocation t(9;22) [BCR/ABL+] (Philadelphia chromosome-positive) or t(4;11) [MLL/AF4+].",
        "exclusion": "* No Down syndrome\n* No other major disease that prohibits study treatment (e.g., severe congenital heart disease)\n* Not requiring significant therapy modification owing to study therapy associated complications\n* No complications due to other interventions\n* No one with missing data that are needed for the differential diagnosis, or for selection of the proper therapy arm"
    }
}